| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > Stealing Proprietary Information from Franchising Companies |
|
Main Subject - Stealing Proprietary Information from Franchising Companies
Corporate Espionage is so great in America that competitors will go to lengths t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product o find out what your company has that makes it so much better than everyone else ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s. Often they will even go so far as to set up a dummy corporation or LLC and ac lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ually go thru the sales process to buy a franchise, sometimes even go thru the p here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rchase process, just to get all the information they need to compete with you, u d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ing your proprietary methods. This is why I came up with a clause in our franch ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ise agreements which helped us in knowing who we are dealing with up front and w easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi at their interests really are. Below is one of the clauses we use; 7.16 Other P nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rties If Franchisee is a partnership, joint venture, association, corporation, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ imited liability company or other legal entity, then all persons who have any be ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi eficial interest in the Franchisee must execute this Franchise Agreement where i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ndicated below and be bound jointly and severally by all the terms and provision dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod hereof, and each such execution shall be a condition precedent to the grant by F cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin anchisee of the Franchised Business. - - - - - - - - - - - This made it very t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ugh for a competitor to risk giving themselves away or opening them up for unfai t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel business practice criminal investigations or civil lawsuits from us. It is unfo ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rtunate that the weaker, underwelming competitors have to cheat and lie just to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eep up, but they are sub human and simply unworthy of mention on the evolutionar . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de food chain. I use to feel sorry for them, but then that 15-second period ended, elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip now we play tough, check six and steamroller these losers. Consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:8 Steps to a Winning Interview Become a Computer Software Engineer
|